News Conference News ACC 2024 IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM Caitlin E. Cox April 15, 2024
News Conference News ESC Heart Failure 2022 Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE Todd Neale May 31, 2022
News Conference News Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward Todd Neale November 16, 2021
News Daily News Microvascular Thrombi Common in Patients Dying of COVID-19 Michael O'Riordan January 27, 2021
News Features Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era Todd Neale November 02, 2020
News Conference News ESC 2020 EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class Michael O'Riordan August 29, 2020
News Conference News TCT 2018 ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year Lucy Hicks September 24, 2018
News Daily News MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes Shelley Wood June 14, 2016
Presentation TCT 2014 Case Selection and Use of Myocardial Contrast Echocardiography During Ablation Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh September 16, 2014
News Daily News Survival After Septal Ablation for HOCM Similar to General Population L.A. McKeown February 06, 2014
News Daily News Percutaneous Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Shows Low Mortality L.A. McKeown May 27, 2011